GSK Articles
GSK looking to sell Affymax
22 March 2001
GSK drops enrasentan after ENCORE results
22 March 2001
US pharma's political contributions in 2000
22 March 2001
Vernalis full-year 2000 losses double
21 March 2001
Informa Pharma Award winners
21 March 2001
Corixa hit by FDA decision on Bexxar
20 March 2001
OGS losses widen to L16.8 million
19 March 2001
Director quits GSK over tobacco company links
15 March 2001
AIDS drug prices slashed in Ivory Coast
15 March 2001
Update - FDA panel rejects pentavalent Infanrix
15 March 2001
AIDS in S Africa "not a national emergency"
15 March 2001
Belgium's Solvay looks for IBS partner
13 March 2001
AIDS drug prices slashed in Ivory Coast
12 March 2001
US panel rejects GSK pentavalent vaccine
9 March 2001
Drug majors cut AIDS drug prices further
7 March 2001
Almogran set for German launch soon?
6 March 2001
Poland "Europe's fifth largest OTC market"
6 March 2001
SkyePharma's DepoCyt gains US clearance
5 March 2001
Pharma targeted by S Africa protests
2 March 2001
GSK, Malaria Vaccine Initiative join forces
1 March 2001
Cipla talks with WHO over AIDS drug offer
1 March 2001
Discovery Partners to acquire Xenometrix
1 March 2001
GSK backs UK R&D tax credits initiative
27 February 2001
10 countries to get Cipla's AIDS drugs
26 February 2001
Kenyan moves to buy cheap AIDS drugs
26 February 2001
GSK "surprise" at SA HIV/AIDS drugs claim
23 February 2001
GSK plans AIDS vaccine trials later this year
23 February 2001
Seroxat cleared for PTSD in UK
22 February 2001
Stock Commentary - Europe
22 February 2001
GSK restructuring its R&D to boost productivity
22 February 2001
GlaxoSmithKline starts life in 2001 on a strong financial footing
21 February 2001
Merck KGaA sets out plan to become number one in core businesses
20 February 2001
HOPE sub-study backs up ramipril benefit
20 February 2001
Pakistan drug supply situation eased
20 February 2001
Indian firms in limbo on patents, pricing
20 February 2001
UK DoH to investigate Zyban safety
19 February 2001
Euro epilepsy drug sales "to grow 17.2%/year"
19 February 2001
Amrad signs $50M R&D deal with GSK
19 February 2001
Merck KGaA CEO weighs up GSK antidepressant deal
16 February 2001
UK GPs prescribing fewer antibiotics
16 February 2001
Loss of GSK contract sees PDI shares slump
16 February 2001
GSK fills product gap by licensing Merck KGaA antidepressant
15 February 2001
Pharmaceutical plants attacked in the UK
13 February 2001
40%-123% US Rx price variations found
13 February 2001
Cipla talks with MNCs over HIV drug offer
13 February 2001
FDA backs Avandia combo therapy
12 February 2001
Stock Commentary - Europe
8 February 2001
Stock Commentary - Tokyo
8 February 2001
Akzo, Solvay combine to push Remeron SolTab in USA
8 February 2001
Aradigm and Genentech drop development of improved CF drug
6 February 2001
Weston terminates deal with J&J unit
5 February 2001
Stock Commentary - Europe
1 February 2001
FDA panel reviews LYMErix safety
1 February 2001
FTC smoking cessation probe of GSK ended
1 February 2001
Earnings increase 41% at BioChem Pharma
1 February 2001
Rwanda HIV drug deal close
31 January 2001
Trimeris and Roche report progress with HIV fusion inhibitors
31 January 2001
US and Euro stock ratings "are full," says Commerzbank
31 January 2001
Stock Commentary - Tokyo
25 January 2001
Stock Commentary - Europe
25 January 2001
GSK/Sequenom link for DNA screening
24 January 2001
Roche plans Tamiflu launch in Japan soon
23 January 2001
European psychotropics market forecasts
22 January 2001
Ranbaxy selling 50% JV stake to Lilly
19 January 2001
Nicholas Piramal no 2 Indian pharma firm
19 January 2001
Stock Commentary - Europe
18 January 2001
GSK unveils restructuring plans in France after merger
18 January 2001
GSK gets EC approval for Block Drug buy
12 January 2001
Hand-held computers "can improve patient safety, create savings"
12 January 2001
Roche names GSK's Abercrombie to heard N Amer pharma ops
12 January 2001
India's Ranbaxy eyes French generics mart
12 January 2001
GSK emphasizes need for hefty R&D spend
10 January 2001
AstraZeneca asthma drug approved in EU
9 January 2001
GSK's Trizivir cleared in EU for HIV
9 January 2001
Warnings issued on use of B-MS' antiretrovirals in pregnancy
8 January 2001
Stock Commentary - Europe
4 January 2001
Novartis completes SB antiviral buy
4 January 2001
Glaxo Wellcome/SmithKline Beecham merger completed at last
3 January 2001
Glaxo Wellcome/SmithKline Beecham merger gets go-ahead from FTC
18 December 2000
GlaxoSmithKline on December 27?
13 December 2000
Glaxo Wellcome/SmithKline Beecham merger still dogged by FTC demands
16 November 2000
GW/SB merger delayed until end of year
11 September 2000
New GSK appointment
31 August 2000
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
